Harpoon Therapeutics Presents Preclinical Data for TriTAC-XR Platform that Supports Potential for Improved Safety by Minimizing Cytokine Release Syndrome
TriTAC-XR demonstrates extended release mechanism that confirms accumulation of active drug which improves therapeutic index…
Apptly Announces $1,000,000 Non-Brokered Private Placement
SATO Technologies Corp. Announces Loan Settlement Eliminating All of Its Senior Secured Debt and C$1.5 Million Private Placement
Theralase(R) Closes C$3.6 Million Brokered Financing